Acute Myeloid Leukemia and Myelodysplastic Syndromes | Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes – A Review of the 2022 ASCO Annual Meeting and EHA Congress

Research To Practice | Oncology Videos · Jul 27, 2022 · 1h 1m

Featuring perspectives from Dr Richard Stone, including the following topics:

Introduction: RATIFY trial in perspective (0:00)

Treatment with FLT3 inhibitors (7:00)

Anti-CD47 antibody: Magrolimab (23:04)

Anti-TIM-3 antibody: Sabatolimab (31:23)

CAR T-cell therapy for acute myeloid leukemia (34:53)

Targeted therapy with IDH inhibitors (37:31)

New myelodysplastic syndromes classification system (41:20)

Hypomethylating agents/venetoclax (45:11)

CPX-351 (49:14)

Other key data sets (50:59)

CME information and select publications